CBR Pharma Insights Market Research Reports





RSS Sort By :
TITLE Price Buy Now More options

GBI Research’s latest report, ""Global Drug Delivery Technologies - Innovation Driven by Rapidly Expanding Injectables Market and Increasing Usage of Complex Biologics during the Forecast Period"" discusses the drug delivery...

$ 2995


GBI Research’s latest report, ""Strategic Trends in Private Equity and Venture Capital Funding for Healthcare"" provides a comprehensive analysis on emerging investment trends within the healthcare industry. Private equity (...

$ 2995


GBI Research’s latest report “The Future of Generic Drugs and Strategies for Commercial Success” discusses trends in the global generic drugs market, and the evolving business strategies being adopted and leveraged by generic dru...

$ 2995


GBI Research’s latest report, ""Stem Cell Therapies Global Trends in the Competitive, Technological and R&D Landscape"" provides an in-depth assessment of the current trends in the global stem cell therapy sector with...

$ 2995


GBI Research’s latest report, ""Innovation Tracking Factbook 2016An Assessment of the Pharmaceutical Pipeline"" is a comprehensive, granular analysis of the 20,756 products currently in the pharmaceutical industry pipelin...

$ 2995


GBI Research's latest report, ""Human Drugs For Veterinary Use Current Trends and Future Commercial Prospects for Crossover Drugs"", discusses global commercial trends and prospects for human medicines applied in the veteri...

$ 2995


GBI Research's latest report, "Substance Abuse Deterrents and Treatments An Assessment of the Technological, Competitive and R&D Landscape", discusses global trends in the substance abuse deterrents and addiction treatments marke...

$ 2995


GBI Research's latest report, ""Telehealth: Global Market Trends, Regulatory Landscape and Operational Strategies"", provides key insights into the global telehealth regulatory and market landscape, as well as its main appl...

$ 2995


SummaryGBI Research's latest report, "Evolving Market Access Strategies - Pricing and Reimbursement Landscape in Major Developed Pharmaceutical Markets" assesses developments within the key el...

$ 2995


GBI Research’s latest report, ""The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects"" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching dru...

$ 2995


GBI Research’s latest report, ""Biobanking: Developing Smart, Sustainable and Ethically Compliant Biorepositories for the Future"" discusses fundamental concepts in biobanking and recent technology advancements in the fie...

$ 2995


GBI Research’s latest report, ""Pharmaceutical Deal Trends (2010–2015) and In-Depth Analysis of Recent Deal Activity"" discusses deal-making trends for a range of deal types, such as Mergers & Acquisitions (M&am...

$ 2995


GBI Research’s latest report, "Gene Therapies: A Diverse Range of Technologies with a Promising Long-Term Outlook" discusses all gene therapies under the broad criteria of genetic material introduced to the cell for a therapeutic p...

$ 2995


GBI Research’s latest report, ""Opioids Overview to 2021 - An Assessment of Pain Management and Dependence"" discusses the use of opioids as potent analgesics for the treatment of cancer and non-cancer pain and examines t...

$ 2995


GBI Research’s latest report, ""Life Cycle Management Strategies - Optimizing revenues and defending generic competition"" discusses various stages of product lifecycle management (LCM), Developmental, co...

$ 2995


Biosimilars are copied versions of biologics that offer a 20-50% reduction in cost compared with innovative biologic products. Biosimilars are getting the world wide attention as the cost of the innovative biologics are enormously high and even mi...

$ 2995


GBI Research’s latest report, "Contract Research Organization Market - Global Deals and Operational Strategies" discusses the deal making activity during the past five years and in-depth analysis of the key deals involving more tha...

$ 2995


Men’s health refers to conditions that specifically affect males, or those that are not gender-specific but have different outcomes in men. Although still dominated by cardiovascular disease, men’s health is increasingly focusing on ot...

$ 2995


Many of the diseases and conditions that affect mainly women are interlinked with similar root causes; however, placing all of the pieces of the puzzle together to ensure a cohesive management strategy remains a challenge. Women’s He...

$ 2995


The report provides analysis of new developments that will have a strong bearing on the use of opioids in pain management in emerging countries (Argentina, Brazil, China, India, Mexico, Russia and South Africa). Access to opioids is restricted und...

$ 2995


The report provides an estimation of 2013 opioid revenues and forecast consumption and revenues until 2023 in the five major Western European countries: the UK, Germany, France, Italy and Spain. The estimated revenues for 2013 are highest in the U...

$ 2995

Live Chat Support
Need Help?
Name
Email
Phone
Country
Subject
Comments

Connect With Us
Email: sales@reportsandreports.com Call : + 1 888 391 5441
Subscription Option

Use our subscription option and keep yourself updated about the latest from CBR Pharma Insights. We have market research reports of all sectors covered by the CBR Pharma Insights; you can access and utilize them at economical budgets.

More about our Subscription option